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Viral respiratory infections in immunocompromised patients, such as those who have just undergone 
hematopoietic cell transplantation (HCT), can range from subclinical infections to pneumonia. Viral 
pneumonias are an important cause of morbidity and mortality in patients undergoing HCT, and can 
be caused by a variety of viruses, including respiratory syncytial virus, coronavirus, and influenza. 
Recent studies suggest that patients with influenza RNA in their blood (viremia) have a worse 
prognosis than patients who have influenza but do not have viremia. It is therefore important for 
patient health to establish this association, and to determine which risk factors contribute to the 
development of viremia. 
To address these issues, senior author Dr. Michael Boeckh and a visiting scientist from South 
Korea, Dr. Su-Mi Choi (Vaccine and Infectious Disease Division) conducted a retrospective study of 
79 influenza-positive HCT patients. Of these patients, nine had detectable influenza RNA in their 
blood, and viremia was significantly more common in patients that progressed to lower respiratory 
disease (LRD, p=0.007). Patients infected with the 2009 H1N1 pandemic strain were more likely to 
develop viremia (p=0.02), and this association held true even when the authors’ statistical models 
accounted for lymphopenia (low white blood cell count) and antiviral treatment. Patients with 
detectable influenza RNA in their blood from any virus strain were at significantly higher risk for poor 
clinical outcomes including low oxygen saturation (p=0.003), respiratory failure (p<0.001), and death 
(p<0.001). 
This is the first study to systematically define the presence of influenza viremia and the associated 
clinical outcomes in HCT patients. The work reported in this study suggests that testing for viremia in 
patients infected with influenza is a useful and important prognostic tool and may be used as an 
endpoint in clinical trials. Future studies will target larger cohorts to both confirm the associations 
found in this study and to define the optimal blood compartment for influenza RNA detection. 
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Schematic diagram of influenza showing the RNA genome 
in the center of the virion. The authors used RT-PCR 
specific to the matrix (M) genes to detect influenza RNA in 
patient blood. 
 
